Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- United States
- United Kingdom
- Canada
- Israel
Investment stages
- Pre-Seed
- Seed
- Series A
Industries
- Artificial Intelligence
- Biology
- Climate
- Robotics
- Frontier Technology
- DeepTech
- Advanced Manufacturing
- Space
About
Compound is a New York-based venture capital firm focused on backing frontier technology founders solving hard scientific problems. Their focus spans AI, biology, climate, robotics, and deep tech across the United States, United Kingdom, Canada, and Israel. The firm supports frontier tech founders from pre-seed through Series A stages.
Compound is a New York-based venture capital firm focused on backing frontier technology founders solving hard scientific problems. Their focus spans AI, biology, climate, robotics, and deep tech across the United States, United Kingdom, Canada, and Israel. The firm supports frontier tech founders from pre-seed through Series A stages.
Investment Thesis
Compound is a pre-seed to Series A stage venture capital firm deploying capital across artificial intelligence, biology, climate, robotics, and frontier technology sectors. They invest as high-conviction lead investors in scientific and technical founders, providing deep research-driven support and long-term partnership. The firm differentiates itself as a specialist frontier tech investor known for its intellectual depth, technical rigor, and commitment to backing founders working on hard scientific problems.
Manager's Experience
Founded and led by Michael Dempsey (Founder and Managing Partner), formerly a VC at Union Square Ventures and CB Insights research analyst who became known for his deep technical writing on frontier technologies including robotics, AI, and neurotechnology. Compound operates with a lean team of technical partners focused on frontier tech investing. The firm's differentiation comes from Dempsey's research-driven approach to identifying and backing scientific and technical founders working on hard problems, with published thesis pieces on emerging fields spanning brain-computer interfaces, robotics, computational biology, and industrial AI. Compound provides hands-on partnership from thesis stage through Series A, with deep technical due diligence and long-term partnership orientation.
Team
Michael Dempsey - Founder & Managing Partner
Diedra Nickerson - Principal
Josh Wolfe - Advisor
Portfolio
Rune Labs
Halcyon
Zume
Ceres Imaging
Fable
Rescale
Ambi Robotics
Nuro
Kepler Communications
Skydio
Overland AI
Vercel
Replicate
Character.AI
Modular
Latent
Chai Discovery